Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure by Jichun Chen, Karen Lipovsky,

Slides:



Advertisements
Similar presentations
Erik Ames, Salif Harouna, Colin Meyer, Lisbeth A. Welniak, William J
Advertisements

An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth by Toshihiko Tanno, Peng Zhang,
Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C
Critical Roles of Lysosomal Acid Lipase in Myelopoiesis
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
by Jad I. Belle, David Langlais, Jessica C
William H. D. Hallett, Weiqing Jing, William R. Drobyski, Bryon D
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease  Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice by Robert G. Newman,
Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis by Maria Rosa Lidonnici, Francesca Corradini,
Continuous in vivo infusion of interferon-gamma (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice by Yue Si, Samantha.
by Neil P. Rodrigues, Viktor Janzen, Randolf Forkert, David M
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Yumi Matsuzaki, Kentaro Kinjo, Richard C Mulligan, Hideyuki Okano 
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Graft-versus-Host Disease Causes Broad Suppression of Hematopoietic Primitive Cells and Blocks Megakaryocyte Differentiation in a Murine Model  Yan Lin,
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging by Matthias Edinger, Yu-An Cao, Michael R. Verneris,
Novel function for interleukin-7 in dendritic cell development
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Jackie R. Bickenbach, Matthew M. Stern, Katie L
Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation by Alice M.
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease by Shan He, Fang.
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy by Fumihiko Tsushima, Sheng Yao, Tahiro Shin, Andrew Flies, Sarah.
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
Volume 1, Issue 6, Pages (December 2007)
A Non-Leaky Artemis-Deficient Mouse That Accurately Models the Human Severe Combined Immune Deficiency Phenotype, Including Resistance to Hematopoietic.
Ovariectomy expands murine short-term hemopoietic stem cell function through T cell expressed CD40L and Wnt10B by Jau-Yi Li, Jonathan Adams, Laura M. Calvi,
A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome by Catherine Lacout,
An acute negative bystander effect of γ-irradiated recipients on transplanted hematopoietic stem cells by Hongmei Shen, Hui Yu, Paulina H. Liang, Haizi.
Low c-Kit Expression Level Induced by Stem Cell Factor Does Not Compromise Transplantation of Hematopoietic Stem Cells  Chia-Ling Chen, Katerina Faltusova,
Allogeneic bone marrow transplant in the absence of cytoreductive conditioning rescues mice with β-thalassemia major by Yongliang Huo, Jonathan R. Lockhart,
TLR5 signaling in murine bone marrow induces hematopoietic progenitor cell proliferation and aids survival from radiation by Benyue Zhang, Damilola Oyewole-Said,
Expression of connexin 43 (Cx43) is critical for normal hematopoiesis
Volume 2, Issue 4, Pages (April 2008)
Evelyn C. Nieves, Tomomi Toubai, Daniel C
by Suzanne M. Vercauteren, and Heather J. Sutherland
Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells
by Xue Li, Jared Sipple, Qishen Pang, and Wei Du
Volume 3, Issue 5, Pages (November 2014)
FTY720 Markedly Increases Alloengraftment but Does Not Eliminate Host Anti-Donor T Cells that Cause Graft Rejection on Its Withdrawal  Patricia A. Taylor,
by Ute Koch, Anne Wilson, Monica Cobas, Rolf Kemler, H
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease by Tangsheng Yi, Dongchang Zhao, Chia-Lei.
Volume 15, Issue 6, Pages (June 2014)
Volume 17, Issue 10, Pages (December 2016)
by Hairui Su, Chiao-Wang Sun, Szu-Mam Liu, Xin He, Hao Hu, Kevin M
Cytotoxic CD8+ T Cells Stimulate Hematopoietic Progenitors by Promoting Cytokine Release from Bone Marrow Mesenchymal Stromal Cells  Christian M. Schürch,
An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth by Toshihiko Tanno, Peng Zhang,
Volume 4, Issue 2, Pages (February 2003)
Mark J. Kiel, Melih Acar, Glenn L. Radice, Sean J. Morrison 
Volume 2, Issue 4, Pages (April 2008)
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
FGF-2 signaling mediates expansion of HSPCs
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells by Xiaoli Wang, Cing Siang Hu, Bruce Petersen, Jiajing.
Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells by Fang Dong, Haitao.
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells by Mia Eriksson, Pablo Peña-Martínez,
Volume 27, Issue 3, Pages (September 2007)
Volume 9, Issue 2, Pages (August 2011)
Volume 1, Issue 3, Pages (September 2007)
Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells  Christian Scheffold, Yolanda C. Scheffold,
Volume 4, Issue 2, Pages (February 2009)
Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation:
Volume 5, Issue 5, Pages (November 2015)
Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure  Zhijie Wu, Valentina Giudice, Jichun Chen, Wanling Sun, Zenghua.
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Nitric Oxide Is a Regulator of Hematopoietic Stem Cell Activity
Jackie R. Bickenbach, Matthew M. Stern, Katie L
by Samuel J. Taylor, Johanna M. Duyvestyn, Samantha A. Dagger, Emma J
Presentation transcript:

Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure by Jichun Chen, Karen Lipovsky, Felicia M. Ellison, Rodrigo T. Calado, and Neal S. Young Blood Volume 104(6):1671-1678 September 15, 2004 ©2004 by American Society of Hematology

BM lymphocyte infiltration and Fas-mediated apoptosis in BM failure mice. BM lymphocyte infiltration and Fas-mediated apoptosis in BM failure mice. Five CByB6F1 mice each received 5 Gy TBI and injections of 5 × 106 B6 LN cells to induce BM failure. Two CByB6F1 mice that received 5 Gy TBI without LN cell injection were used as controls. At 14 days, all mice were bled, and serum IFN-γ concentrations were analyzed using ELISA (top left). BM cells were analyzed by flow cytometry for the proportions of CD4 (top center) and CD8 (top right) lymphocytes, for the expression of CD95 (Fas, middle row), and for the binding to annexin V (bottom row). Data in the top row are presented as means with standard error bars. Jichun Chen et al. Blood 2004;104:1671-1678 ©2004 by American Society of Hematology

BM oligoclonal T-cell expansion in mice with BM failure. BM oligoclonal T-cell expansion in mice with BM failure. BM cells from control and BM failure B6D2F1 mice were analyzed for the expression of Vβ TCR repertoire. Proportions of each specific Vβ TCR repertoire relative to the sum of all 15 Vβ TCR repertoires (Vβ 2, 3, 4, 5.1/5.2, 6, 7, 8.1/8.2, 8.3, 9, 10, 11, 12, 13, 14, 17a) on BM CD8+ T cells were compared between BM failure mice and control mice. Data shown are fold increases in each Vβ TCR repertoire in BM failure mice from 3 independent experiments. Jichun Chen et al. Blood 2004;104:1671-1678 ©2004 by American Society of Hematology

Elimination of BM Lin-Sca1+CD117+ hematopoietic progenitor and stem cells. Elimination of BM Lin-Sca1+CD117+ hematopoietic progenitor and stem cells. BM cells from 15 control and 15 BM failure mice were stained with an antibody cocktail containing CD34-FITC, Sca1-PE, Lin (CD3, CD4, CD8, CD11b, CD19, Gr1, Ter119)-biotin, and CD117 (c-Kit)-APC and were analyzed using a BD-LSR flow cytometer. Data shown are expressions of Sca1 and CD117 on BM Lin- cells (top panels) and expressions of CD34 on Lin-Sca1+CD117+ BM cells (bottom panels) of control and BM failure mice. Jichun Chen et al. Blood 2004;104:1671-1678 ©2004 by American Society of Hematology

Elimination of BM hematopoietic progenitor and stem cells. Elimination of BM hematopoietic progenitor and stem cells. BM Lin-Sca1+c-Kit+CD34+, Lin-Sca1+c-Kit+CD34-, and Lin-Sca1+c-Kit+ cell proportions from 15 control and 15 BM failure mice were each multiplied by the total number of BM cells of each mouse, assuming that 2 tibiae and 2 femurs contained 25% of total BM cells, to calculate total cell numbers (top left). Two BM cell pools, each from 3 BM failure mice, and BM cells from 2 untreated control mice were tested for day 12 CFU-S, shown as total CFU-S per mouse (top right). BM cells pooled from 4 BM failure CByB6F1 mice were serial diluted from 1:2 to 1: 64, whereas BM cells from 2 untreated CByB6F1 control donors were diluted from 1:32 to 1:128, and each cell dilution was used to rescue 4 or 2 lethally irradiated (10 Gy) recipients. Recipient survival was monitored for 2 months (for those that received control BM) but only shown for 30 days here (bottom). Data presented in the top row are means with standard error bars. Jichun Chen et al. Blood 2004;104:1671-1678 ©2004 by American Society of Hematology

Destruction of BM hematopoietic progenitor and stem cells as bystanders. Destruction of BM hematopoietic progenitor and stem cells as bystanders. Sublethally irradiated B6D2F1 mice (5 Gy TBI) were infused with 5 × 106 normal B6 (CD45.2) LN cells to induce BM failure. BM cells from 2 affected mice and 1 control mouse that did not receive LN cell infusion were mixed 1:2 with BM from a B6-CD45.1 congenic codonor, and the cell mixtures were then transplanted into new lethally irradiated, B6D2F1 recipients at 5 recipients per donor. Three recipients each received 10 × 105 B6-CD45.1 congenic codonor BM cells and were used as controls. Recipient survival and donor engraftment were monitored for 10 weeks (A). Sublethally irradiated CByB6F1 mice (5 Gy TBI) were infused with 5 × 106 normal B6 (CD45.2) LN cells to induce BM failure. BM from 1 affected mouse (moderate for BM failure to ensure recipient survival) was mixed 1:2 with BM from a B6-CD45.1 congenic codonor and was injected into 6 lethally irradiated CByB6F1 recipients. Of these, 3 recipients were intraperitoneally injected with 500 μg/d anti-IFN-γ on days 0 and 9, and the other 3 recipients were not. BM cells from 1 control CByB6F1 mouse that did not receive LN cell infusion were mixed 1:2 with BM from a B6-CD45.1 congenic codonor and were injected into 3 lethally irradiated CByB6F1 recipients. Recipients were analyzed 3 weeks after transplantation for CBC and total BM cellularity (B). In both parts of study, each recipient received 5 × 105 donor and 10 × 105 codonor BM cells. Data in panel B are means ± standard error. Jichun Chen et al. Blood 2004;104:1671-1678 ©2004 by American Society of Hematology

Stromal cells as bystanders. Stromal cells as bystanders. BM cells from CByB6F1 mice treated with 5 Gy TBI and 5 × 106 B6 LN cell infusion 14 days earlier were mixed 1:2 with BM cells from a healthy B6 mouse, and the cell mixtures were then transplanted into new lethally irradiated CByB6F1 recipients. After 2 weeks, BM cells extracted from the recipients were cultured in α-MEM at 33°C with 5% CO2 along with BM cells from 2 fresh CByB6F1 mice to establish stromal feeder layers After 4 weeks in cell culture, fresh BM cells were overlaid on the established feeder layers. Stromal feeder developed from normal CByB6F1 marrow (left) supported marrow cell growth, but stromal cells from cotransplantation recipients could not establish a feeder layer to support marrow growth (right). Jichun Chen et al. Blood 2004;104:1671-1678 ©2004 by American Society of Hematology